GlobalData on MSN5d
Globus Medical strengthens SCS market position with $250m Nevro deal
GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Boston Scientific Co. (NYSE:BSX) Given Consensus Recommendation of “Buy” by Brokerages
Boston Scientific Co. (NYSE:BSX – Get Free Report) has been given an average recommendation of “Buy” by the twenty-three ...
Raymond James Boosts Boston Scientific (NYSE:BSX) Price Target to $122.00
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective lifted by equities research analysts at Raymond James ...
Neurostimulation Devices Market Valuation To Surpass US$ 22.64 Billion by 2033 | Astute Analytica
Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations while engineers refine cooling techniques, improve battery resilience, and ...
PharmiWeb11d
Top 10 Wearable Artificial Organs Players: Leading Companies Revolutionizing Healthcare
Introduction to Wearable Artificial OrgansThe field of wearable artificial organs (WAOs) is a game-changer in modern medicine, offering innovative solutions that replicate the functions of human ...
Canaccord maintains Buy rating, $101 target on Globus Medical stock
Canaccord Genuity maintained a Buy rating with a $101.00 price target for Globus Medical (NYSE:GMED) shares, which currently trades at $88.54. The firm's analysis supports the company's ongoing ...
Two doctors help patients with spinal cord injuries walk again
A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...